172 related articles for article (PubMed ID: 17622486)
1. Safety and efficacy of fractionated stereotactic radiotherapy for acoustic neuromas.
McClelland S; Gerbi BJ; Higgins PD; Orner JB; Hall WA
J Neurooncol; 2008 Jan; 86(2):191-4. PubMed ID: 17622486
[TBL] [Abstract][Full Text] [Related]
2. The treatment of a large acoustic tumor with fractionated stereotactic radiotherapy.
McClelland S; Gerbi BJ; Cho KH; Hall WA
J Robot Surg; 2007; 1(3):227-30. PubMed ID: 25484968
[TBL] [Abstract][Full Text] [Related]
3. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy.
McClelland S; Higgins PD; Gerbi BJ; Orner JB; Hall WA
Technol Cancer Res Treat; 2007 Jun; 6(3):177-80. PubMed ID: 17535025
[TBL] [Abstract][Full Text] [Related]
4. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
[TBL] [Abstract][Full Text] [Related]
5. Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital.
Koh ES; Millar BA; Ménard C; Michaels H; Heydarian M; Ladak S; McKinnon S; Rutka JA; Guha A; Pond GR; Laperriere NJ
Cancer; 2007 Mar; 109(6):1203-10. PubMed ID: 17318817
[TBL] [Abstract][Full Text] [Related]
6. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas.
Fuss M; Debus J; Lohr F; Huber P; Rhein B; Engenhart-Cabillic R; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1381-7. PubMed ID: 11121637
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
8. Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.
Chen Z; Takehana K; Mizowaki T; Uto M; Ogura K; Sakanaka K; Arakawa Y; Mineharu Y; Miyabe Y; Mukumoto N; Miyamoto S; Hiraoka M
Int J Clin Oncol; 2018 Aug; 23(4):608-614. PubMed ID: 29556918
[TBL] [Abstract][Full Text] [Related]
9. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
10. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation.
Champ CE; Shen X; Shi W; Mayekar SU; Chapman K; Werner-Wasik M; Farrell CJ; Gunn V; Downes MB; Liu H; Evans JJ; Andrews DW
Neurosurgery; 2013 Sep; 73(3):489-96. PubMed ID: 23756743
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience.
Sakanaka K; Mizowaki T; Arakawa Y; Araki N; Oya N; Takahashi JA; Mikuni N; Miyamoto S; Hashimoto N; Hiraoka M
Int J Clin Oncol; 2011 Feb; 16(1):27-32. PubMed ID: 20830603
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
[TBL] [Abstract][Full Text] [Related]
13. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
14. Fractionated stereotactic radiotherapy for acoustic neuromas: preservation of function versus size.
Williams JA
J Clin Neurosci; 2003 Jan; 10(1):48-52. PubMed ID: 12464521
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy for the treatment of acoustic neuromas.
Selch MT; Pedroso A; Lee SP; Solberg TD; Agazaryan N; Cabatan-Awang C; DeSalles AA
J Neurosurg; 2004 Nov; 101 Suppl 3():362-72. PubMed ID: 15537191
[TBL] [Abstract][Full Text] [Related]
16. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.
Chan AW; Black P; Ojemann RG; Barker FG; Kooy HM; Lopes VV; McKenna MJ; Shrieve DC; Martuza RL; Loeffler JS
Neurosurgery; 2005 Jul; 57(1):60-70; discussion 60-70. PubMed ID: 15987541
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery and radiotherapy for acoustic neuromas.
Kalogeridi MA; Kougioumtzopoulou A; Zygogianni A; Kouloulias V
Neurosurg Rev; 2020 Jun; 43(3):941-949. PubMed ID: 30982152
[TBL] [Abstract][Full Text] [Related]
19. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
